Evolution of inhibitor-resistant natural mutant forms of HIV-1 protease probed by pre-steady state kinetic analysis-Reference-Cited by-同舟云学术

Evolution of inhibitor-resistant natural mutant forms of HIV-1 protease probed by pre-steady state kinetic analysis

Published:2017-11 Issue: Volume:142 Page:125-134
ISSN:0300-9084
Container-title:Biochimie
language:en
Short-container-title:Biochimie

Author:

Zakharova Maria Yu.,Kuznetsova Alexandra A.,Kaliberda Elena N.,Dronina Maria A.,Kolesnikov Alexander V.,Kozyr Arina V.,Smirnov Ivan V.,Rumsh Lev D.,Fedorova Olga S.^ORCID,Knorre Dmitry G.,Gabibov Alexander G.,Kuznetsov Nikita A.^ORCID

Funder

Russian Science Foundation

Publisher

Elsevier BV

Subject

General Medicine,Biochemistry

Reference30 articles.

1. Inhibitors of HIV-1 protease: a major success of structure-assisted drug design;Wlodawer;Annu. Rev. Biophys. Biomol. Struct.,1998

2. Defining HIV-1 protease substrate selectivity;Beck;Curr. Drug Targets Infect. Disord.,2002

3. Insights into a mutation-assisted lateral drug escape mechanism from the HIV-1 protease active site;Sadiq;Biochemistry,2007

4. Unique thermodynamic response of tipranavir to human immunodeficiency virus type 1 protease drug resistance mutations;Muzammil;J. Virol.,2007

5. A major role for a set of non-active site mutations in the development of HIV-1 protease drug resistance;Muzammil;Biochemistry,2003

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pre-Steady-State Kinetics of the SARS-CoV-2 Main Protease as a Powerful Tool for Antiviral Drug Discovery;Frontiers in Pharmacology;2021-12-06

2. FÁRMACOS ANTIMICROBIANOS E ANTIVIRAIS COM POTENCIAL USO TERAPÊUTICO PARA A COVID-19;Infarma - Ciências Farmacêuticas;2020-07-07